Stock Price Quote

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE672.408.45 (+1.27 %)
PREV CLOSE ( ) 663.95
OPEN PRICE ( ) 666.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 35753
TODAY'S LOW / HIGH ( )662.25 674.90
52 WK LOW / HIGH ( )397.3 667.35
NSE672.008 (+1.2 %)
PREV CLOSE( ) 664.00
OPEN PRICE ( ) 669.00
BID PRICE (QTY) 672.00 (3458)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1398313
TODAY'S LOW / HIGH( ) 662.50 674.75
52 WK LOW / HIGH ( )397.2 665.75
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman K Nithyananda Reddy - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone 040-23736370/23747340

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

30May Aurobindo Pharma surges on getting nod
Aurobindo Pharma is currently trading at Rs. 628.50, up by 17.30 points..
29May Aurobindo Pharma gets nod to sell stak
Aurobindo Pharma has received approval from board of directors for sale..
29May Aurobindo Pharma reports 12% fall in Q
Aurobindo Pharma has reported results for fourth quarter (Q4) and year e..
26May Aurobindo Pharma’s arm receives USFDA’
Aurobindo Pharma’s wholly owned subsidiary company -- Eugia Pharma Speci..
20May USFDA completes inspection at Unit XIV
The United States Food and Drug Administration (USFDA) has completed ins..

Financials

in Millions
QTR Mar 23 ANNUAL 23
Net Profit644812304.1
Gross Profit 8160.3 16143.5
Operating Profit 980021646.8
Net Sales 35474.4127922.8

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  2994.40 (2.78%)
M.Cap ( in Cr)3841.78
NGL Fine-Chem (BSE)
peergroup  1518.85 (3.90%)
M.Cap ( in Cr)938.35
Abbott India (BSE)
peergroup  21872.60 (0.21%)
M.Cap ( in Cr)46477.75
JB Chem & Pharma (BSE)
peergroup  2159.50 (1.89%)
M.Cap ( in Cr)16718.18
Themis Medicare (BSE)
peergroup  1509.00 (2.70%)
M.Cap ( in Cr)1388.70

Shareholding Pattern

MUTUAL FUNDS/UTI 7.64%
FI/BANKS/INSURANCE 7.2%
PROMOTERS 51.83%
NON-INSTITUTION 10.05%
GOVERNMENT 0%
FII 0%

About Aurobindo Pharma Ltd.

Aurobindo Pharma Ltd. was incorporated in the year 1986. Its today's share price is 672.4. Its current market capitalisation stands at Rs 39398.51 Cr. In the latest quarter, company has reported Gross Sales of Rs. 113503.1 Cr and Total Income of Rs.119759.9 Cr. The company's management includes Santanu Mukherjee, B Adi Reddy, Girish Vanvari, Savita Mahajan, Avnit Bimal Singh, PV Ramprasad Reddy, P Sarath Chandra Reddy, M Madan Mohan Reddy, M Sivakumaran, K Nithyananda Reddy, K Ragunathan.

It is listed on the BSE with a BSE Code of 524804 , NSE with an NSE Symbol of AUROPHARMA and ISIN of INE406A01037. It's Registered office is at Plot No. 2,Maitrivihar ,AmeerpetHyderabad-500038, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates LLP, K Nagaraju & Associates, SR Batliboi & Associates, SR Batliboi & Associates LLP, SR Batliboi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)